BRISBANE, Calif.--(BUSINESS WIRE)--Aimmune Therapeutics, Inc. (Nasdaq:AIMT), a biopharmaceutical company developing desensitization treatments for food allergies, today announced that its financial results for the fourth quarter and full year 2015 will be released on Thursday, March 3, 2016, after the markets close. At 5:00 p.m. Eastern Time, Aimmune management will host a conference call to discuss its financial results and provide a general business update.
